VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EVOLVE104 takes on tough cancers in early human trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell carcinoma (lung, esophagus, skin, and others). The study aims to find a safe dose and see if the drug can shrink tumors. It is for pati…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug duo offers hope for hard-to-treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that has come back, spread, or is too advanced for surgery or radiation. About 42 participants will receive the combination. The main goal is to see how many have thei…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo aims to fight Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether two drugs, pembrolizumab and lenvatinib, can shrink or control vulvar cancer that cannot be surgically removed. About 80 participants will receive the combination in 21-day cycles. The study will measure tumor response and track side effects.
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Vulvar cancer breakthrough: surgery tailored by virus and gene status
Disease control Recruiting nowThis study aims to see if matching the extent of surgery to the specific type of vulvar cancer (based on HPV infection and p53 gene changes) can reduce the chance of the cancer coming back. About 249 women with early-stage vulvar squamous cell carcinoma will take part. The goal i…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and sid…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a single dye replace the standard two-step test for vulvar cancer spread?
Diagnosis Recruiting nowThis study compares a dye called ICG alone against the standard two-method approach (ICG plus a radioactive tracer) to find cancer in lymph nodes of women with early vulvar cancer. About 58 women will take part. If ICG alone works just as well, it could simplify surgery and reduc…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Sponsor: Hamilton Health Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Vulvar cancer breakthrough: one test could spare women unnecessary surgery
Knowledge-focused Recruiting nowThis study is testing whether looking at two biological markers (HPV and p53) in early-stage vulvar cancer can help doctors decide the right amount of surgery. Some women may need less surgery, while others may need more. The study will follow 249 participants for 3 years to see …
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood test and patient surveys aim to outsmart vulva cancer recurrence
Knowledge-focused Recruiting nowThis study is testing whether regular patient surveys and a special blood test (circulating tumor DNA) can spot vulva cancer returning earlier than standard check-ups. About 295 women with vulva cancer will fill out symptom surveys every four months and give blood samples for two…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC